This report aims to provide a comprehensive presentation of the global market for Ankylosing Spondylitis Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ankylosing Spondylitis Treatment Drug. This report contains market size and forecasts of Ankylosing Spondylitis Treatment Drug in global, including the following market information:
Global Ankylosing Spondylitis Treatment Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Ankylosing Spondylitis Treatment Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Non-steroidal Anti-inflammatory Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ankylosing Spondylitis Treatment Drug include Abbott, Merck, Eisai, Novartis, Pfizer, Johson & Johson, Abbive, UCB and Amgen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ankylosing Spondylitis Treatment Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ankylosing Spondylitis Treatment Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Ankylosing Spondylitis Treatment Drug Market Segment Percentages, by Type, 2022 (%)
Non-steroidal Anti-inflammatory Drugs
Inhibitor
Global Ankylosing Spondylitis Treatment Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Ankylosing Spondylitis Treatment Drug Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Other
Global Ankylosing Spondylitis Treatment Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Ankylosing Spondylitis Treatment Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ankylosing Spondylitis Treatment Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Ankylosing Spondylitis Treatment Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Merck
Eisai
Novartis
Pfizer
Johson & Johson
Abbive
UCB
Amgen
Takeda
Mitsubishi Tanabe
Hisun Pharm
Guojian Pharmaceutical
Bio-Thera Solutions
Maibo Pharma
Celgen Pharm
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ankylosing Spondylitis Treatment Drug, market overview.
Chapter 2: Global Ankylosing Spondylitis Treatment Drug market size in revenue.
Chapter 3: Detailed analysis of Ankylosing Spondylitis Treatment Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ankylosing Spondylitis Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ankylosing Spondylitis Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ankylosing Spondylitis Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ankylosing Spondylitis Treatment Drug Overall Market Size
2.1 Global Ankylosing Spondylitis Treatment Drug Market Size: 2022 VS 2030
2.2 Global Ankylosing Spondylitis Treatment Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ankylosing Spondylitis Treatment Drug Players in Global Market
3.2 Top Global Ankylosing Spondylitis Treatment Drug Companies Ranked by Revenue
3.3 Global Ankylosing Spondylitis Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Ankylosing Spondylitis Treatment Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Ankylosing Spondylitis Treatment Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ankylosing Spondylitis Treatment Drug Players in Global Market
3.6.1 List of Global Tier 1 Ankylosing Spondylitis Treatment Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Ankylosing Spondylitis Treatment Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ankylosing Spondylitis Treatment Drug Market Size Markets, 2022 & 2030
4.1.2 Non-steroidal Anti-inflammatory Drugs
4.1.3 Inhibitor
4.2 By Type - Global Ankylosing Spondylitis Treatment Drug Revenue & Forecasts
4.2.1 By Type - Global Ankylosing Spondylitis Treatment Drug Revenue, 2018-2023
4.2.2 By Type - Global Ankylosing Spondylitis Treatment Drug Revenue, 2024-2030
4.2.3 By Type - Global Ankylosing Spondylitis Treatment Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ankylosing Spondylitis Treatment Drug Market Size, 2022 & 2030
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.1.5 Other
5.2 By Application - Global Ankylosing Spondylitis Treatment Drug Revenue & Forecasts
5.2.1 By Application - Global Ankylosing Spondylitis Treatment Drug Revenue, 2018-2023
5.2.2 By Application - Global Ankylosing Spondylitis Treatment Drug Revenue, 2024-2030
5.2.3 By Application - Global Ankylosing Spondylitis Treatment Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Ankylosing Spondylitis Treatment Drug Market Size, 2022 & 2030
6.2 By Region - Global Ankylosing Spondylitis Treatment Drug Revenue & Forecasts
6.2.1 By Region - Global Ankylosing Spondylitis Treatment Drug Revenue, 2018-2023
6.2.2 By Region - Global Ankylosing Spondylitis Treatment Drug Revenue, 2024-2030
6.2.3 By Region - Global Ankylosing Spondylitis Treatment Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Ankylosing Spondylitis Treatment Drug Revenue, 2018-2030
6.3.2 US Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.3.3 Canada Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.3.4 Mexico Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Ankylosing Spondylitis Treatment Drug Revenue, 2018-2030
6.4.2 Germany Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.4.3 France Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.4.4 U.K. Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.4.5 Italy Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.4.6 Russia Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.4.7 Nordic Countries Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.4.8 Benelux Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Ankylosing Spondylitis Treatment Drug Revenue, 2018-2030
6.5.2 China Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.5.3 Japan Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.5.4 South Korea Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.5.5 Southeast Asia Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.5.6 India Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Ankylosing Spondylitis Treatment Drug Revenue, 2018-2030
6.6.2 Brazil Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.6.3 Argentina Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue, 2018-2030
6.7.2 Turkey Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.7.3 Israel Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
6.7.5 UAE Ankylosing Spondylitis Treatment Drug Market Size, 2018-2030
7 Ankylosing Spondylitis Treatment Drug Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.1.4 Abbott Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.2.4 Merck Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Eisai
7.3.1 Eisai Company Summary
7.3.2 Eisai Business Overview
7.3.3 Eisai Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.3.4 Eisai Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.3.5 Eisai Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.4.4 Novartis Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.5.4 Pfizer Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Johson & Johson
7.6.1 Johson & Johson Company Summary
7.6.2 Johson & Johson Business Overview
7.6.3 Johson & Johson Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.6.4 Johson & Johson Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.6.5 Johson & Johson Key News & Latest Developments
7.7 Abbive
7.7.1 Abbive Company Summary
7.7.2 Abbive Business Overview
7.7.3 Abbive Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.7.4 Abbive Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.7.5 Abbive Key News & Latest Developments
7.8 UCB
7.8.1 UCB Company Summary
7.8.2 UCB Business Overview
7.8.3 UCB Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.8.4 UCB Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.8.5 UCB Key News & Latest Developments
7.9 Amgen
7.9.1 Amgen Company Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.9.4 Amgen Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.9.5 Amgen Key News & Latest Developments
7.10 Takeda
7.10.1 Takeda Company Summary
7.10.2 Takeda Business Overview
7.10.3 Takeda Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.10.4 Takeda Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.10.5 Takeda Key News & Latest Developments
7.11 Mitsubishi Tanabe
7.11.1 Mitsubishi Tanabe Company Summary
7.11.2 Mitsubishi Tanabe Business Overview
7.11.3 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.11.4 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.11.5 Mitsubishi Tanabe Key News & Latest Developments
7.12 Hisun Pharm
7.12.1 Hisun Pharm Company Summary
7.12.2 Hisun Pharm Business Overview
7.12.3 Hisun Pharm Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.12.4 Hisun Pharm Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.12.5 Hisun Pharm Key News & Latest Developments
7.13 Guojian Pharmaceutical
7.13.1 Guojian Pharmaceutical Company Summary
7.13.2 Guojian Pharmaceutical Business Overview
7.13.3 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.13.4 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.13.5 Guojian Pharmaceutical Key News & Latest Developments
7.14 Bio-Thera Solutions
7.14.1 Bio-Thera Solutions Company Summary
7.14.2 Bio-Thera Solutions Business Overview
7.14.3 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.14.4 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.14.5 Bio-Thera Solutions Key News & Latest Developments
7.15 Maibo Pharma
7.15.1 Maibo Pharma Company Summary
7.15.2 Maibo Pharma Business Overview
7.15.3 Maibo Pharma Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.15.4 Maibo Pharma Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.15.5 Maibo Pharma Key News & Latest Developments
7.16 Celgen Pharm
7.16.1 Celgen Pharm Company Summary
7.16.2 Celgen Pharm Business Overview
7.16.3 Celgen Pharm Ankylosing Spondylitis Treatment Drug Major Product Offerings
7.16.4 Celgen Pharm Ankylosing Spondylitis Treatment Drug Revenue in Global Market (2018-2023)
7.16.5 Celgen Pharm Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Ankylosing Spondylitis Treatment Drug Market Opportunities & Trends in Global Market
Table 2. Ankylosing Spondylitis Treatment Drug Market Drivers in Global Market
Table 3. Ankylosing Spondylitis Treatment Drug Market Restraints in Global Market
Table 4. Key Players of Ankylosing Spondylitis Treatment Drug in Global Market
Table 5. Top Ankylosing Spondylitis Treatment Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Ankylosing Spondylitis Treatment Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Ankylosing Spondylitis Treatment Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Ankylosing Spondylitis Treatment Drug Product Type
Table 9. List of Global Tier 1 Ankylosing Spondylitis Treatment Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ankylosing Spondylitis Treatment Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Ankylosing Spondylitis Treatment Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Ankylosing Spondylitis Treatment Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Ankylosing Spondylitis Treatment Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Ankylosing Spondylitis Treatment Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2024-2030
Table 30. Abbott Company Summary
Table 31. Abbott Ankylosing Spondylitis Treatment Drug Product Offerings
Table 32. Abbott Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck Ankylosing Spondylitis Treatment Drug Product Offerings
Table 36. Merck Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Key News & Latest Developments
Table 38. Eisai Company Summary
Table 39. Eisai Ankylosing Spondylitis Treatment Drug Product Offerings
Table 40. Eisai Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Eisai Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Ankylosing Spondylitis Treatment Drug Product Offerings
Table 44. Novartis Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Ankylosing Spondylitis Treatment Drug Product Offerings
Table 48. Pfizer Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Johson & Johson Company Summary
Table 51. Johson & Johson Ankylosing Spondylitis Treatment Drug Product Offerings
Table 52. Johson & Johson Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Johson & Johson Key News & Latest Developments
Table 54. Abbive Company Summary
Table 55. Abbive Ankylosing Spondylitis Treatment Drug Product Offerings
Table 56. Abbive Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Abbive Key News & Latest Developments
Table 58. UCB Company Summary
Table 59. UCB Ankylosing Spondylitis Treatment Drug Product Offerings
Table 60. UCB Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 61. UCB Key News & Latest Developments
Table 62. Amgen Company Summary
Table 63. Amgen Ankylosing Spondylitis Treatment Drug Product Offerings
Table 64. Amgen Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Amgen Key News & Latest Developments
Table 66. Takeda Company Summary
Table 67. Takeda Ankylosing Spondylitis Treatment Drug Product Offerings
Table 68. Takeda Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Takeda Key News & Latest Developments
Table 70. Mitsubishi Tanabe Company Summary
Table 71. Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Product Offerings
Table 72. Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Mitsubishi Tanabe Key News & Latest Developments
Table 74. Hisun Pharm Company Summary
Table 75. Hisun Pharm Ankylosing Spondylitis Treatment Drug Product Offerings
Table 76. Hisun Pharm Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Hisun Pharm Key News & Latest Developments
Table 78. Guojian Pharmaceutical Company Summary
Table 79. Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Product Offerings
Table 80. Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 81. Guojian Pharmaceutical Key News & Latest Developments
Table 82. Bio-Thera Solutions Company Summary
Table 83. Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Product Offerings
Table 84. Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 85. Bio-Thera Solutions Key News & Latest Developments
Table 86. Maibo Pharma Company Summary
Table 87. Maibo Pharma Ankylosing Spondylitis Treatment Drug Product Offerings
Table 88. Maibo Pharma Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 89. Maibo Pharma Key News & Latest Developments
Table 90. Celgen Pharm Company Summary
Table 91. Celgen Pharm Ankylosing Spondylitis Treatment Drug Product Offerings
Table 92. Celgen Pharm Ankylosing Spondylitis Treatment Drug Revenue (US$, Mn) & (2018-2023)
Table 93. Celgen Pharm Key News & Latest Developments
List of Figures
Figure 1. Ankylosing Spondylitis Treatment Drug Segment by Type in 2022
Figure 2. Ankylosing Spondylitis Treatment Drug Segment by Application in 2022
Figure 3. Global Ankylosing Spondylitis Treatment Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ankylosing Spondylitis Treatment Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Ankylosing Spondylitis Treatment Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ankylosing Spondylitis Treatment Drug Revenue in 2022
Figure 8. By Type - Global Ankylosing Spondylitis Treatment Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Ankylosing Spondylitis Treatment Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Ankylosing Spondylitis Treatment Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Ankylosing Spondylitis Treatment Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global Ankylosing Spondylitis Treatment Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America Ankylosing Spondylitis Treatment Drug Revenue Market Share, 2018-2030
Figure 16. US Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Ankylosing Spondylitis Treatment Drug Revenue Market Share, 2018-2030
Figure 20. Germany Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Ankylosing Spondylitis Treatment Drug Revenue Market Share, 2018-2030
Figure 28. China Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Ankylosing Spondylitis Treatment Drug Revenue Market Share, 2018-2030
Figure 34. Brazil Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue Market Share, 2018-2030
Figure 37. Turkey Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Ankylosing Spondylitis Treatment Drug Revenue, (US$, Mn), 2018-2030
Figure 41. Abbott Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eisai Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johson & Johson Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Abbive Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. UCB Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Amgen Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Takeda Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Hisun Pharm Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Maibo Pharma Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Celgen Pharm Ankylosing Spondylitis Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
